期刊文献+

Pelvic radiation therapy: Between delight and disaster 被引量:3

Pelvic radiation therapy: Between delight and disaster
下载PDF
导出
摘要 In the last few decades radiotherapy was established as one of the best and most widely used treatmentmodalities for certain tumours. Unfortunately that came with a price. As more people with cancer survive longer an ever increasing number of patients are living with the complications of radiotherapy and have become, in certain cases, difficult to manage. Pelvic radiation disease(PRD) can result from ionising radiationinduced damage to surrounding non-cancerous tissues resulting in disruption of normal physiological functions and symptoms such as diarrhoea, tenesmus, incontinence and rectal bleeding. The burden of PRDrelated symptoms, which impact on a patient's quality of life, has been under appreciated and sub-optimally managed. This article serves to promote awareness of PRD and the vast potential there is to improve current service provision and research activities. In the last few decades radiotherapy was established as one of the best and most widely used treatmentmodalities for certain tumours. Unfortunately that came with a price. As more people with cancer survive longer an ever increasing number of patients are living with the complications of radiotherapy and have become, in certain cases, difficult to manage. Pelvic radiation disease(PRD) can result from ionising radiationinduced damage to surrounding non-cancerous tissues resulting in disruption of normal physiological functions and symptoms such as diarrhoea, tenesmus, incontinence and rectal bleeding. The burden of PRDrelated symptoms, which impact on a patient’s quality of life, has been under appreciated and sub-optimally managed. This article serves to promote awareness of PRD and the vast potential there is to improve current service provision and research activities.
出处 《World Journal of Gastrointestinal Surgery》 SCIE CAS 2015年第11期279-288,共10页 世界胃肠外科杂志(英文版)(电子版)
关键词 PELVIC RADIOTHERAPY Radiation TOXICITY Pelvic radiotherapy Radiation Toxicity
  • 相关文献

参考文献20

  • 1H. J. N. Andreyev.Pelvic radiation disease[J]. Colorectal Dis . 2015 (1)
  • 2Chanatip Metheetrairut,Frank J Slack.MicroRNAs in the ionizing radiation response and in radiotherapy[J]. Current Opinion in Genetics & Development . 2013 (1)
  • 3Linda J. Wedlake,Foteini Silia,Barbara Benton,Amyn Lalji,Karen Thomas,David P. Dearnaley,Peter Blake,Diana Tait,Vincent S. Khoo,H. Jervoise N. Andreyev.Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies[J]. European Journal of Cancer . 2012 (14)
  • 4Nhue L. Do,Deborah Nagle,Vitaliy Y. Poylin,Jean S. Wang.Radiation Proctitis: Current Strategies in Management[J]. Gastroenterology Research and Practice . 2011
  • 5C.C. Henson,H.J. Andreyev,R.P. Symonds,D. Peel,R. Swindell,S.E. Davidson.Late-onset Bowel Dysfunction after Pelvic Radiotherapy: A National Survey of Current Practice and Opinions of Clinical Oncologists[J]. Clinical Oncology . 2011 (8)
  • 6H. Jervoise N. Andreyev,Andrew Wotherspoon,James W. Denham,Martin Hauer-Jensen.“Pelvic radiation disease”: New understanding and new solutions for a new disease in the era of cancer survivorship[J]. Scandinavian Journal of Gastroenterology . 2011 (4)
  • 7Eamonn M.M. Quigley,Ahmed Abu-Shanab.Small Intestinal Bacterial Overgrowth[J]. Infectious Disease Clinics of North America . 2010 (4)
  • 8Jordi Giralt,José Perez Regadera,Ramona Verges,Jesus Romero,Isabel de la Fuente,Albert Biete,Jesús Villoria,Jose Maria Cobo,Francisco Guarner.Effects of Probiotic Lactobacillus Casei DN-114 001 in Prevention of Radiation-Induced Diarrhea: Results From Multicenter, Randomized, Placebo-Controlled Nutritional Trial[J]. International Journal of Radiation Oncology, Biology, Physics . 2008 (4)
  • 9H. Andreyev.Argon plasma coagulation in chronic radiation proctitis: Postgate et al.[J]. Endoscopy . 2007 (08)
  • 10Jervoise Andreyev.Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients[J]. Lancet Oncology . 2007 (11)

共引文献5

同被引文献26

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部